Nocturia as an Unrecognized Symptom of Uncontrolled Hypertension in Black Men Aged 35 to 49 Years.

Background Hypertension is assumed to be asymptomatic. Yet, clinically significant nocturia (≥2 nightly voids) constitutes a putative symptom of uncontrolled hypertension. Black men with hypertension may be prone to nocturia because of blunted nocturnal blood pressure ( BP ) dipping, diuretic drug use for hypertension, and comorbidity that predisposes to nocturia. Here, we test the hypothesis that nocturia is a common and potentially reversible symptom of uncontrolled hypertension in black men. Methods and Results We determined the strength of association between nocturia (≥2 nightly voids) and high BP (≥135/85 mm Hg) by conducting in-person health interviews and measuring BP with an automated monitor in a large community-based sample of black men in their barbershops. Because nocturia is prevalent and steeply age-dependent after age 50 years, we studied men aged 35 to 49 years. Among 1673 black men (mean age, 43±4 years [ SD ]), those with hypertension were 56% more likely than men with normotension to have nocturia after adjustment for diabetes mellitus and sleep apnea (adjusted odds ratio, 1.56; 95% CI , 1.25-1.94 [ P<0.0001]). Nocturia prevalence varied by hypertension status, ranging from 24% in men with normotension to 49% in men whose hypertension was medically treated but uncontrolled. Men with untreated hypertension were 39% more likely than men with normotension to report nocturia ( P=0.02), whereas men whose hypertension was treated and controlled were no more likely than men with normotension to report nocturia ( P=0.69). Conclusions Uncontrolled hypertension was an independent determinant of clinically important nocturia in a large cross-sectional community-based study of non-Hispanic black men aged 35 to 49 years. Clinical Trial Registration URL : http://www.clinicaltrials.gov . Unqiue identifier: NCT 02321618

Mental health, social connectedness, and fear during the COVID-19 pandemic: a qualitative perspective from older women with HIV.

Older women with HIV (WWH) confront significant biopsychosocial challenges that may be exacerbated by the COVID-19 pandemic. Between May 2020 and April 2021, following a resiliency intervention conducted as part of a randomized parent trial, 24 cisgender WWH (M = 58 years old) completed quantitative assessments and qualitative interviews exploring the impact of COVID-19 on mental health. Qualitative data were analyzed via rapid analysis. Most participants were Black (62.5%) and non-Hispanic or Latina (87.5%). Emergent themes included (1) increased anxiety and depression; (2) a loss of social connectedness; (3) fear of unknown interactions among COVID-19, HIV, and other comorbidities; and (4) the use of largely adaptive strategies to cope with these issues. Findings suggest that older WWH face significant COVID-19-related mental health challenges, compounding existing stressors. As the pandemic persists, it will be important to assess the impact of these stressors on wellbeing, identify effective coping strategies, and provide increased support to mitigate COVID-19-related mental health issues over time. Trial Registration: ClinicalTrials.gov identifier: NCT03071887.R34 AT009170 - NCCIH NIH HHS; T32 MH116140 - NIMH NIH HHS; 5R34AT009170 - NCCIH NIH HHSAccepted manuscrip

The Relationship Between IQ, Memory, Executive Function, and Processing Speed in Recent-Onset Psychosis: 1-Year Stability and Clinical Outcome

Studies commonly report poor performance in psychotic patients compared with controls on tasks testing a range of cognitive functions, but, because current IQ is often not matched between these groups, it is difficult to determine whether this represents a generalized deficit or specific abnormalities. Fifty-three first-episode psychosis patients and 53 healthy controls, one-to-one matched for sex, age, and full-scale current IQ, were compared on Wechsler Adult Intelligence Scale (WAIS) subtests representing indices of perceptual organization, verbal comprehension, processing speed, and working memory as well as other tests of executive function and episodic memory. The groups showed an equivalent pattern of performance on all WAIS subtests except digit symbol processing speed, on which the patients were significantly worse. Patients were also worse on measures where performance correlated with digit symbol score, namely working and verbal memory tasks. Standardized residual scores for each subtest were calculated for each patient using the difference between their actual subtest score and a predicted subtest score based on their full-scale IQ and the performance of controls. Scaled scores and residual scores were examined for relationships with clinical measures. Digit symbol–scaled score was significantly correlated with concurrent negative syndrome score at baseline, and digit symbol residual score significantly predicted residual negative symptoms at 1-year follow-up. In summary, our comparison of patients and controls precisely matched for IQ revealed that processing speed was attenuated in recent-onset schizophrenia, contributed significantly to working and episodic memory deficits, and was a prognostic factor for poor outcome at 1 year

Variability independent of mean blood pressure as a real-world measure of cardiovascular risk

BackgroundIndividual-level blood pressure (BP) variability, independent of mean BP levels, has been associated with increased risk for cardiovascular events in cohort studies and clinical trials using standardized BP measurements. The extent to which BP variability relates to cardiovascular risk in the real-world clinical practice setting is unclear. We sought to determine if BP variability in clinical practice is associated with adverse cardiovascular outcomes using clinically generated data from the electronic health record (EHR).MethodsWe identified 42,482 patients followed continuously at a single academic medical center in Southern California between 2013 and 2019 and calculated their systolic and diastolic BP variability independent of the mean (VIM) over the first 3 years of the study period. We then performed multivariable Cox proportional hazards regression to examine the association between VIM and both composite and individual outcomes of interest (incident myocardial infarction, heart failure, stroke, and death).FindingsBoth systolic (HR, 95% CI 1.22, 1.17–1.28) and diastolic VIM (1.24, 1.19–1.30) were positively associated with the composite outcome, as well as all individual outcome measures. These findings were robust to stratification by age, sex and clinical comorbidities. In sensitivity analyses using a time-shifted follow-up period, VIM remained significantly associated with the composite outcome for both systolic (1.15, 1.11–1.20) and diastolic (1.18, 1.13–1.22) values.InterpretationVIM derived from clinically generated data remains associated with adverse cardiovascular outcomes and represents a risk marker beyond mean BP, including in important demographic and clinical subgroups. The demonstrated prognostic ability of VIM derived from non-standardized BP readings indicates the utility of this measure for risk stratification in a real-world practice setting, although residual confounding from unmeasured variables cannot be excluded.</p

IQ Trajectory, Cognitive Reserve, and Clinical Outcome Following a First Episode of Psychosis: A 3-Year Longitudinal Study

Comparison of current and estimated premorbid IQ in schizophrenia suggests that there are subgroups with low IQ, deteriorated IQ (DIQ), or preserved IQ and that this is established by psychosis onset. There are no controlled studies examining the trajectory of these IQ subgroups longitudinally or their relationship with clinical and social outcomes. Of 129 individuals with first-episode schizophrenia or schizoaffective disorder, 25% showed stable low IQ, 31% showed stable IQ in the average/high range, and 44% demonstrated intellectual deterioration by 10 points or more. Patients in the low and deteriorated groups were equally impaired on tests of memory and executive function compared with the preserved average/high-IQ group and controls and showed more negative and disorganization symptoms than the preserved average/high-IQ group. Sixty patients and 27 controls were assessed again 1 and 3 years later. There was no evidence that those with IQ deterioration at baseline continued on a declining cognitive trajectory or that those with preserved average/high IQ experienced subsequent IQ decline. The low IQ group showed no change in IQ, whereas both the DIQ and the preserved IQ groups improved. However, the rate of improvement of these 2 subgroups was no greater than that of the healthy controls, suggesting that this reflected practice effects. Both the low and the deteriorated groups had longer index admissions, more core negative symptoms, and worse occupational outcomes at 3 years. These data suggest that following psychosis onset, IQ is stable and that it is IQ at psychosis onset rather than premorbid IQ predicts a more severe illness

Flow of viscoelastic fluids between plates rotating about distinct axes

We discuss the flow of BKZ fluids in an orthogonal rheometer. Some analytical results are proved, and numerical solutions are obtained for the Currie model. These solutions show a boundary layer behavior at high Reynolds numbers and the possibility of discontinuous solutions or nonexistence at high Weissenberg numbers.Peer Reviewedhttp://deepblue.lib.umich.edu/bitstream/2027.42/47205/1/397_2005_Article_BF01774396.pd

Vantagem competitiva, criação de valor e seus efeitos sobre o desempenho

Competitive advantage is the main hypothesis to explain the firm performance heterogeneity. However, competitive advantage is frequently simplified and empirically treated as profitability, despite its implications for the overall firm performance. Considering that, this article develops a metric for competitive advantage by means of the analysis of its effects over financial performance, combining the curves of profitability and market share growth. Using a multilevel model, the individual results for each firm is isolated and tested against each sector mean. The model is applied to a sample of American companies (COMPUSTAT), in four intervals during the period of 1990 to 2009. The results reveal different competitive configurations, in which 16% of the firms are positioned in advantage and 16,5% in disadvantage (2005-2009),considering that the analysis for the other intervals demonstrated stability of the results.A vantagem competitiva é a principal hipótese para explicar a heterogeneidade do desempenho entre as empresas. No entanto, vantagem competitiva é frequentemente tratada empiricamente como rentabilidade superior simplesmente, desprezando as demais implicações para o desempenho das empresas. Sob esse prisma, este trabalho desenvolve uma métrica para vantagem competitiva e pela avaliação de seus efeitos sobre o desempenho financeiro, combinando as curvas de lucratividade e de crescimento em participação de mercado. Por meio de um modelo multinível, são isolados os resultados individuais de cada empresa e posteriormente testados em relação à média dos seus setores. O modelo é aplicado a amostras de empresas americanas (Compustat), em quatro intervalos de tempo, ao longo do período de 1990 a 2009. Os resultados permitem identificar diferentes configurações de competitividade, com 16% de empresas em posição de vantagem e outros 16,5% em desvantagem (2005-2009), sendo que o teste para os demais intervalos demonstrou estabilidade dos resultados.La ventaja competitiva es la principal hipótesis para explicar la heterogeneidad del desempeño entre las empresas. No obstante, la ventaja competitiva es, con frecuencia, tratada empíricamente como simple rentabilidad superior, despreciando las demás implicaciones para el desempeño de las empresas. Bajo ese prisma, este trabajo desarrolla una métrica para la ventaja competitiva y por la evaluación de sus efectos sobre el desempeño financiero, combinando las curvas de lucratividad y de crecimiento en participación de mercado. Por medio de un modelo multinivel, son aislados los resultados individuales de cada empresa y posteriormente probados en relación a la media de sus sectores. El modelo es aplicado a muestras de empresas norteamericanas (Compustat), en cuatro intervalos de tiempo, a lo largo del período 1990-2009. Los resultados permiten identificar diferentes configuraciones de competitividad, con 16% de empresas en posición de ventaja y otros 16,5% en desventaja (2005-2009), mientras que el test para los demás intervalos demostró estabilidad de los resultados